전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Jemal A, Thomas A, Murray T, Thun M. 2002. Cancer statistics. CA: Cancer J, Clin. 52: 23-47.
    Pubmed
  2. Chang DK, Merrett ND, Biankin AV. 2008. Pancreatic Cancer Network, Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem? J. Gastroenterol. Hepatol. 23: 1036-1045.
    Pubmed
  3. Welsch T, Degrate L, Zschabitz S, Hofer S, Werner J. 2011. The need for extended intensive care after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. Langenbecks Arch. Surg. 396: 353-362.
    Pubmed
  4. Guha S, Lunn JA, Santiskulvong C, Rozengurt E. 2003. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. Cancer Res. 63: 2379-2387.
  5. Kokkinakis DM, Liu XY, Neuner RD. 2005. Modulation of cell cycle and gene expression in pancreatic tumor cell lines by methionine deprivation (methionine stress): implications to the therapy of pancreatic adenocarcinoma. Mol. Cancer Ther. 4: 1338-1348.
    Pubmed
  6. Awale S, Lu J, Kalauni SK, Kurashima Y, Tezuka Y, Kadota S, Esumi, H. 2006. Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation. Cancer Res. 66: 1751-1757.
    Pubmed
  7. Izuishi K, Kato K, Ogura T, Kinoshita T, Esumi H. 2000. Remarkable tolerance of tumor cells to nutrient deprivation: possible new biochemical target for cancer therapy. Cancer Res. 60, 6201-6207.
  8. Ogiso Y, Tomida A, Lei S, Omura S, Tsuruo T. 2000. Proteasome inhibition circumvents solid tumor resistance to topoisomerase IIdirected drug. Cancer Res. 60: 2429-2434.
  9. Semenza GL. 2003. Angiogenesis in ischemic and neoplastic disorders. Annu. Rev. Med. 54: 17-28.
    Pubmed
  10. Luo S, Baumeister P, Yang S, Abcouwer SF, Lee AS. 2003. Induction of Grp78/BiP by translational block: activation of the Grp78 promoter by ATF4 through and upstream ATF/CRE site independent of the endoplasmic reticulum stress elements. J. Biol. Chem. 278: 37375-37385.
    Pubmed
  11. Park HR, Tomida A, Sato S, Tsukumo Y, Yun J, Yamori T, et al. 2004. Effect on tumor cells of blocking survival response to glucose deprivation. J. Natl. Cancer Inst. 17: 1300-1310.
    Pubmed
  12. Park HR, Ryoo IJ, Choo SJ, Hwang JH, Kim JY, Cha MR, et al. 2007. Glucose-deprivated HT-29 human colon carcinoma cells are sensitive to verrucosidin as a GRP78 down-regulator. Toxicology 229: 253-261.
    Pubmed
  13. Hetz C, Bernasconi P, Fisher J, Lee AH, Bassik MC, Antocsson B, et al. 2006. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1a. Science 312: 572-576.
    Pubmed
  14. Li J, Lee AS. 2006. Stress induction of GRP/BiP and its role in cancer. Curr. Mol. Med. 6: 45-54.
    Pubmed
  15. Zhang K, Kaufman RJ. 2004. Signaling the unfolded protein response from the Endoplasmic reticulum. J. Biol. Chem. 279: 2593525938.
    Pubmed
  16. Garber K. 2006. Researchers target unfolded protein response in cancerous tumor growth. J. Natl. Cancer Inst. 98: 152-154.
    Pubmed
  17. Choi AR, Lee IK, Woo EE, Kwon JW, Yun BS, Park HR. 2015. New glabretal triterpenes from the immature fruits of Poncirus trifoliate and their selective cytotoxicity. Chem. Pharm. Bull. 63: 1065-1069.
    Pubmed
  18. Lee AS. 2007. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 67: 3496-3499.
    Pubmed
  19. Fu Y, Lee AS. 2006. Glucose regulated proteins in cancer progression, drug resistance and immunotherapy. Cancer Biol. Ther. 5: 741744.
    Pubmed
  20. Tsujimoto Y, Cossman J, Jaffe E, Croce CM. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 14401443.
    Pubmed
  21. Hu W, Kavanagh JJ. 2003. Anticancer therapy targeting the apoptotic pathway. Lancet Oncol. 4: 721-729.
  22. Kaufmann SH, Hengartner MO. 2001. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11: 526-534.
  23. Jin Z, El-Deiry WS. 2005. Overview of cell death signaling pathways. Cancer Biol. Ther. 4: 139-163.
    Pubmed
  24. Ghobrial IM, Witzig TE, Adjei AA. 2005. Targeting apoptosis pathways in cancer therapy. CA: Cancer J, Clin. 55: 178-194.
    Pubmed
  25. Kozutsumi Y, Segal M, Normington K, Gething MJ, Sambrook J. 1988. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 332: 462-464.
    Pubmed
  26. Kaufman RJ. 1999. Stress signalling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13: 1211-1233.
    Pubmed
  27. Sausville EA. 2004. Versipelostatin: unfolding an unsweetened death. J. Natl. Cancer Inst. 96: 1266-1267.
    Pubmed
  28. Yun J, Tomida A, Nagata K, Tsuruo T. 1995. Glucose-regulated stresses confer resistnace to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol. Res. 7: 583-590.
  29. Tomida A, Tsuruo T. 1999. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anticancer Drug Des. 14: 169-177.
  30. Gazit G, Lu J, Lee AS. 1999. De-regulation of GRP stress protein expression in human breast cancer cell line. Breast Cancer Res. Treat. 54: 135-146.
    Pubmed
  31. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS. 2003. Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitor. J. Biol. Chem. 278: 20915-20924.
    Pubmed
  32. Kaufman RJ. 2002. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110: 1389-1398.
    Pubmed
  33. Little E, Ramakrishnan M, Roy B, Gazit G, Lee AS. 1994. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. Crit. Rev. Eukaryot. Gene Expr. 4: 1-18.
    Pubmed
  34. Kang HT, Hwang ES. 2006. 2-Deoxyglucsoe: An anticancer and antiviral therapeutic, but not anymore a low glucose mimetic. Life Sci. 78: 1392-1399.
    Pubmed
  35. Kim DH, Bae EA, Han MJ. 1999. Anti-Helicobacter pylori activity of the metabolites of poncirin from Poncirus trifoliata by human intestinal bacteria. Biol. Pharm. Bull. 22: 422-424.
    Pubmed